Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-07-05 1:38 pm Purchase | 13G | Akero Therapeutics Inc. AKRO | Versant Venture Capital VI L.P. | 4,104,858 14.7% | 4,104,858 (New Position) | View |
| 2019-06-28 8:29 pm Purchase | 13D | Akero Therapeutics Inc. AKRO | ATP Life Science Ventures L.P. | 5,415,203 19.4% | 5,415,203 (New Position) | View |
| 2019-06-26 4:20 pm Purchase | 13D | Akero Therapeutics Inc. AKRO | venBio Global Strategic Fund II L.P. | 3,954,858 14.17% | 3,954,858 (New Position) | View |